Drawing for CARL

USPTO serial 79309225

CARL

Reviewed by CopyMark Law Group

Reg. 6874476Status 700Registered
Filing date
Status date
Registration date
Oct 18, 2022
Examiner
DERBY, KAREN SHEREE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with CARL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Alan E. Schiavelli

Alan E. Schiavelli Fitch, Even, Tabin & Flannery LLP120 South LaSalle StreetSuite 2100Chicago, IL 60603

Goods and services

ClassDescriptionStatusFirst use
005Medical and veterinary preparations and articles, namely, for treatment of heart reduced output, cardiac arrhythmias, cardiac arrest, and stroke, and for resuscitation; pharmaceuticals and natural remedies for the treatment of heart reduced output, cardiac arrhythmias, cardiac arrest, and stroke, and for the purpose of resuscitation; diagnostic preparations for medical and veterinary use for detecting physiological and blood-specific properties of a human or an animal; medical dressings, medical coverings and medical applicators for cover and reseal of wounds and applicators prefilled with medical drugs for treatment of heart reduced output, cardiac arrhythmias, cardiac arrest, and stroke, in particular for resuscitation; blood for medical use for treatment of heart reduced output, cardiac arrhythmias, cardiac arrest, and stroke, in particular for resuscitation or blood substitute for medical use for treatment of heart reduced output, cardiac arrhythmias, cardiac arrest, and stroke, in particular for resuscitation; medicines for veterinary purposes for the treatment of heart reduced output, cardiac arrhythmias, cardiac arrest, and stroke, and resuscitation; biological preparations for medical purposes for the treatment of heart reduced output, cardiac arrhythmias, cardiac arrest, and stroke, and for resuscitation; biological preparations for veterinary and medical purposes for the treatment of heart reduced output, cardiac arrhythmias, cardiac arrest, and stroke, and for resuscitation; blood for medical purposes; blood components for medical purposes for treatment of heart reduced output, cardiac arrhythmias, cardiac arrest, and stroke, and for resuscitation; blood substitutes for medical and veterinary use for treatment of heart reduced output, cardiac arrhythmias, cardiac arrest, and stroke, and for resuscitation; blood plasma; enzymes for veterinary purposes; enzyme preparations for medical purposes; enzyme preparations for veterinary purposes; solid oxygen for medical use; gases for medical purposes; gas mixtures for medical use; haemoglobin; cooling sprays for medical purposes; pharmaceutical preparations for veterinary use for the treatment of heart reduced output, cardiac arrhythmias, cardiac arrest, and stroke, and for resuscitation; radioactive substances for medical purposes; solidified gases for medical purposes; veterinary preparations for the treatment of heart reduced output, cardiac arrhythmias, cardiac arrest, and stroke, and for resuscitationACTIVE—
009Measuring, detecting and monitoring instruments, indicators and controllers for measuring, detecting, and monitoring electrical, physiological and chemical properties of biological organism, including a human or an animal for scientific research uses, namely, for measuring, detecting, and monitoring electrical, physiological and chemical properties of people suffering cardiac arrest, and from whom blood has been withdrawn, analyzed and modified, and into whom the modified blood and/or a chosen substance is introduced before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; automatic dosage apparatus, namely, machines for dispensing pre-determined dosages of medication, in particular, medical drugs, and blood or blood substitute for influencing physiological and chemical blood properties; electronic indicator panels for indicating body activity and function of a human or an animal not for medical use; electric monitoring units for monitoring body activities of a human or an animal for scientific research uses, namely, for monitoring body activities of people suffering cardiac arrest, and from whom blood has been withdrawn, analyzed and modified, and into whom the modified blood and/or a chosen substance is introduced before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; electric monitoring control apparatus for monitoring and controlling body activity and function of a human or an animal, including cardiac activity for scientific research uses, namely, for controlling cardiac activity, and body activity and function of people suffering cardiac arrest, and from whom blood has been withdrawn, analyzed and modified, and into whom the modified blood and/or a chosen substance is introduced before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessaryACTIVE—
010Cardio training equipment for physical therapy purposes all designed specifically for medical use, namely, ergometers for medical testing purposes, bicycle ergometers for medical testing purposes, indoor cycles, treadmill, crosstrainers in the nature of ellipticals, rowing machine ergometers for medical purposes, stepper devices; physiotherapy and rehabilitation equipment designed specifically for medical use, namely, shoulder stretcher using resistance cables, treadmills, stepper, and indoor bicycles; apparatus for the therapeutic stimulation of the muscles, including the heart muscle by applying electrodes on the chest, namely, electronic muscle stimulators for medical purposes; cardio training devices, namely, body rehabilitation apparatus for medical purposesACTIVE—
039Rescue services; rescue of peopleACTIVE—
041Training for handling scientific instruments and apparatus for research in laboratories; education services, namely, providing courses of instruction in the field of therapeutic treatments, namely, instruction in a method of treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; training services in the field of health and safety, namely, instruction in a method of treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; training services in the field of occupational health, namely, instruction in a method of treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; medical education services in the nature of courses of instruction in the field of treatment of people suffering cardiac arrest by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; educational services in the nature of courses of instruction in the field of first aid, namely, instruction in a method of treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; training services for medical visitors in the field of treatment of people suffering cardiac arrest by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; teaching services in the nature of courses of instruction in the surgical field, namely, instruction in a method of treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; education services in the nature of courses of instruction in the field of medicine, namely, instruction in a method of treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; training services in the field of first aid, namely, instruction in a method of treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; workshops for educational purposes in the field of treatment of people suffering cardiac arrest by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessaryACTIVE—
044Ambulant medical care, namely, treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; physician services, namely, treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; medical care, namely, treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; services for the provision of medical care information, namely, providing information concerning treatment of people suffering cardiac arrest by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; medical analysis of human tissues for medical treatment; therapeutic treatment of the body in the nature of medical treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; telemedicine services; Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals used in the treatment of people suffering cardiac arrest, as part of a regimen that includes withdrawing blood from the patient, analyzing and modifying the blood with pharmaceuticals and introducing the modified blood and/or a chosen pharmaceutical substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; medical and pharmaceutical consultation; physical therapy; emergency medical assistance, namely, treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; medical assistance, namely, treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; medical services, namely, treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; medical services for the diagnosis of conditions of the human body, namely, withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; medical services for the treatment of conditions of the human body, namely, treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; medical evaluation services, namely, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; medical advisory services, namely, providing medical advice regarding treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing the blood before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; medical treatment services, namely, treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; physical rehabilitation; medical health assessment services; medical testing services, namely, medical testing of blood for purposes of introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; medical clinic services, namely, treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; surgery, namely, surgical treatment of people suffering cardiac arrest, by surgically withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; medical services for the diagnosis of conditions of the human body, namely, withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; medical services for the treatment of conditions of the human body, namely, treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; medical evaluation services, namely, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; medical advisory services, namely, providing medical advice regarding treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing the blood before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; medical treatment services, namely, treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; physical rehabilitation; medical health assessment services; medical testing services, namely, medical testing of blood for purposes of introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; medical clinic services, namely, treatment of people suffering cardiac arrest, by withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessary; surgery, namely, surgical treatment of people suffering cardiac arrest, by surgically withdrawing blood from the patient, analyzing and modifying the blood and introducing the modified blood and/or a chosen substance into the patient body before starting conventional measures of resuscitation, such as heart rhythm massage and/or defibrillation, if necessaryACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 27, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 4, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 3, 2023FIMPFINAL DISPOSITION PROCESSED—
Jan 18, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Oct 18, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Oct 18, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 17, 2022OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Sep 28, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Sep 28, 2022OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Aug 9, 2022GPNXNOTIFICATION PROCESSED BY IB—
Aug 2, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 2, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 13, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jul 13, 2022OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jul 13, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 25, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 25, 2022XAECEXAMINER'S AMENDMENT ENTERED—
Jun 25, 2022GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 25, 2022GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 25, 2022CNEAEXAMINERS AMENDMENT -WRITTEN—
May 11, 2022GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
May 11, 2022GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 11, 2022CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 12, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 12, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 12, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 3, 2021DOCKASSIGNED TO EXAMINER—
Aug 15, 2021RFNPREFUSAL PROCESSED BY IB—
Jul 13, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 13, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 13, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 8, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 7, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 7, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 31, 2021RFNTREFUSAL PROCESSED BY IB—
May 8, 2021RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 6, 2021RFRRREFUSAL PROCESSED BY MPU—
May 5, 2021RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 4, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 27, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 23, 2021DOCKASSIGNED TO EXAMINER—
Apr 23, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 22, 2021REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance